Growth Factors of Drug Delivery Market
The global drug delivery market is experiencing significant growth, driven by the increasing prevalence of chronic diseases, technological advancements, and a shift towards patient-centric healthcare solutions. According ta report by Fortune Business Insights, the market size stood at USD 1,021.29 billion in 2018 and is projected treach USD 1,801.54 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 7.4% during the forecast period.
Technological Advancements and Digitalization
The pharmaceutical industry is undergoing a transformation with a strong emphasis on digitalization. Manufacturers are integrating digital technologies intdrug delivery systems tenhance patient adherence, wellness, and education. For instance, Insulet Corporation's Omnipod, a wearable device for diabetes management, is designed tbe smart, waterproof, and discreet, providing patients and caregivers with peace of mind.
The trend towards digital health solutions is not only improving therapeutic outcomes but alsensuring that patients receive the proper therapeutic dose for their diagnosed conditions. This shift is driving the need for novel and smart medication delivery systems, such as wearables and connected devices, which offer features like adherence tracking and dosing reminders.
Innovative Product Launches
The introduction of new products with large-volume doses, smart technology, and user-friendly attributes has increased the demand for advanced drug administration systems. The popularity of ocular inserts, insulin jets, wearables, and other innovative products has provided greater efficiency and customer satisfaction. Significant investments by producers in understanding patient needs and introducing products that match these requirements are projected taugment market growth. For example, West Pharmaceutical Services Inc. launched the NovaPure 3ml cartridge for the delivery of higher-volume injectable medicines.
Patient Preference and Home-based Care
There is a rising patient preference for advanced drug administration systems over conventional methods. This shift is anticipated tdrive market growth during the forecast period. The adoption of home-based care and self-administration is increasing, supported by the development of user-friendly devices enabled with smart technology. This trend not only enhances patient convenience but alsreduces the burden on healthcare facilities.
Regional Market Insights
North America dominated the global drug delivery market in 2018, with a market size of USD 428.0 billion. This dominance is attributed tthe increasing number of patients adopting drug delivery devices and the presence of major pharmaceutical companies in the region. Europe held the second-largest market share, driven by the rising penetration of large pharmaceutical companies and the increasing burden of diseases in the region.
Challenges and Restraints
Despite the positive outlook, the market faces challenges such as stringent regulations imposed on the approval of combination drugs. Frequently changing regulatory norms may deter manufacturers from investing heavily in research and development, potentially hindering the introduction of innovative products. Additionally, the high cost of advanced devices and limited reimbursement policies, especially in emerging countries, may limit market adoption.
Future Outlook
The drug delivery market is poised for substantial growth, driven by technological advancements, patient-centric approaches, and the increasing prevalence of chronic diseases. The focus on digitalization and the introduction of smart, user-friendly devices are expected tenhance patient adherence and therapeutic outcomes. However, addressing regulatory challenges and ensuring affordability will be crucial tfully realize the market's potential.
In conclusion, the global drug delivery market is undergoing a significant transformation, with technological innovations and patient preferences shaping its future trajectory. Manufacturers and stakeholders must navigate regulatory landscapes and cost challenges tleverage the opportunities presented by this evolving market.
ATTRIBUTE DETAILS
Study Period - 2015 -2026
Base Year - 2018
Forecast Period - 2019-2026
Historical Period - 2015-2017
Unit Value (USD Billion)
Segmentation By Route of Administration
- Injectable
- Inhalation
- Topical & Transdermal
- Oral
- Others
- Conventional
- Advanced
- Hospital Pharmacies
- Retail Pharmacies
- Others
- North America (the U.S. and Canada)
- Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia Pacific)
- Latin America (Brazil, Mexico, and the Rest of Latin America)
- Middle East & Africa (South Africa, GCC and the Rest of Middle East & Africa)
Please Note: It will take 5-6 business days to complete the report upon order confirmation.
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 4. Key Insights
- 4.1. New Product Launch
- 4.2. Pipeline Analysis
- 4.3. Technological Advancements in the Drug Delivery Market
- 4.4. Key Industry Developments - Mergers, Acquisitions, and Partnerships
- 5. Global Drug Delivery Market Analysis, Insights and Forecast, 2015-2026
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Route of Administration
- 5.2.1. Injectable
- 5.2.2. Inhalation
- 5.2.3. Topical & Transdermal
- 5.2.4. Oral
- 5.2.5. Others
- 5.3. Market Analysis, Insights and Forecast – By Type
- 5.3.1. Conventional
- 5.3.2. Advanced
- 5.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 5.4.1. Hospital Pharmacies
- 5.4.2. Retail Pharmacies
- 5.4.3. Others
- 5.5. Market Analysis, Insights and Forecast – By Geography
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa
- 6. North America Drug Delivery Market Analysis, Insights and Forecast, 2015-2026
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Route of Administration
- 6.2.1. Injectable
- 6.2.2. Inhalation
- 6.2.3. Topical & Transdermal
- 6.2.4. Oral
- 6.2.5. Others
- 6.3. Market Analysis, Insights and Forecast – By Type
- 6.3.1. Conventional
- 6.3.2. Advanced
- 6.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 6.4.1. Hospital Pharmacies
- 6.4.2. Retail Pharmacies
- 6.4.3. Others
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
- 7. Europe Drug Delivery Market Analysis, Insights and Forecast, 2015-2026
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Route of Administration
- 7.2.1. Injectable
- 7.2.2. Inhalation
- 7.2.3. Topical & Transdermal
- 7.2.4. Oral
- 7.2.5. Others
- 7.3. Market Analysis, Insights and Forecast – By Type
- 7.3.1. Conventional
- 7.3.2. Advanced
- 7.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 7.4.1. Hospital Pharmacies
- 7.4.2. Retail Pharmacies
- 7.4.3. Others
- 7.5. Market Analysis, Insights and Forecast – By Country/Sub-region
- 7.5.1. U.K.
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Spain
- 7.5.5. Italy
- 7.5.6. Scandinavia
- 7.5.7. Rest of Europe
- 8. Asia Pacific Drug Delivery Market Analysis, Insights and Forecast, 2015-2026
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Route of Administration
- 8.2.1. Injectable
- 8.2.2. Inhalation
- 8.2.3. Topical & Transdermal
- 8.2.4. Oral
- 8.2.5. Others
- 8.3. Market Analysis, Insights and Forecast – By Type
- 8.3.1. Conventional
- 8.3.2. Advanced
- 8.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 8.4.1. Hospital Pharmacies
- 8.4.2. Retail Pharmacies
- 8.4.3. Others
- 8.5. Market Analysis, Insights and Forecast – By Country/Sub-region
- 8.5.1. Japan
- 8.5.2. China
- 8.5.3. India
- 8.5.4. Australia
- 8.5.5. Southeast Asia
- 8.5.6. Rest of Asia Pacific
- 9. Latin America Drug Delivery Market Analysis, Insights and Forecast, 2015-2026
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Route of Administration
- 9.2.1. Injectable
- 9.2.2. Inhalation
- 9.2.3. Topical & Transdermal
- 9.2.4. Oral
- 9.2.5. Others
- 9.3. Market Analysis, Insights and Forecast – By Type
- 9.3.1. Conventional
- 9.3.2. Advanced
- 9.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 9.4.1. Hospital Pharmacies
- 9.4.2. Retail Pharmacies
- 9.4.3. Others
- 9.5. Market Analysis, Insights and Forecast – By Country/Sub-region
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America
- 10. Middle East & Africa Drug Delivery Market Analysis, Insights and Forecast, 2015-2026
- 10.1. Key Findings / Summary
- 10.2. Market Analysis, Insights and Forecast – By Route of Administration
- 10.2.1. Injectable
- 10.2.2. Inhalation
- 10.2.3. Topical & Transdermal
- 10.2.4. Oral
- 10.2.5. Others
- 10.3. Market Analysis, Insights and Forecast – By Type
- 10.3.1. Conventional
- 10.3.2. Advanced
- 10.4. Market Analysis, Insights and Forecast – By Distribution Channel
- 10.4.1. Hospital Pharmacies
- 10.4.2. Retail Pharmacies
- 10.4.3. Others
- 10.5. Market Analysis, Insights and Forecast – By Country/Sub-region
- 10.5.1. GCC Countries
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
- 11. Competitive Analysis
- 11.1. Key Industry Developments
- 11.2. Global Market Share Analysis (2018)
- 11.3. Competition Dashboard
- 11.4. Comparative Analysis – Major Players
- 11.5. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
- 11.5.1. BD
- 11.5.1.1. Overview,
- 11.5.1.2. Products & Services,
- 11.5.1.3. SWOT Analysis,
- 11.5.1.4. Recent Developments,
- 11.5.1.5. Strategies,
- 11.5.1.6. Financials (Based on Availability)
- 11.5.2. Emergent Biosolutions Inc.
- 11.5.2.1. Overview,
- 11.5.2.2. Products & Services,
- 11.5.2.3. SWOT Analysis,
- 11.5.2.4. Recent Developments,
- 11.5.2.5. Strategies,
- 11.5.2.6. Financials (Based on Availability)
- 11.5.3. Consort Medical plc
- 11.5.3.1. Overview,
- 11.5.3.2. Products & Services,
- 11.5.3.3. SWOT Analysis,
- 11.5.3.4. Recent Developments,
- 11.5.3.5. Strategies,
- 11.5.3.6. Financials (Based on Availability)
- 11.5.4. Aptar Pharma
- 11.5.4.1. Overview,
- 11.5.4.2. Products & Services,
- 11.5.4.3. SWOT Analysis,
- 11.5.4.4. Recent Developments,
- 11.5.4.5. Strategies,
- 11.5.4.6. Financials (Based on Availability)
- 11.5.5. West Pharmaceutical Services Inc.
- 11.5.5.1. Overview,
- 11.5.5.2. Products & Services,
- 11.5.5.3. SWOT Analysis,
- 11.5.5.4. Recent Developments,
- 11.5.5.5. Strategies,
- 11.5.5.6. Financials (Based on Availability)
- 11.5.6. Insulet Corporation
- 11.5.6.1. Overview,
- 11.5.6.2. Products & Services,
- 11.5.6.3. SWOT Analysis,
- 11.5.6.4. Recent Developments,
- 11.5.6.5. Strategies,
- 11.5.6.6. Financials (Based on Availability)
- 11.5.7. Nemera
- 11.5.7.1. Overview,
- 11.5.7.2. Products & Services,
- 11.5.7.3. SWOT Analysis,
- 11.5.7.4. Recent Developments,
- 11.5.7.5. Strategies,
- 11.5.7.6. Financials (Based on Availability)
- 11.5.8. SHL Medical AG.
- 11.5.8.1. Overview,
- 11.5.8.2. Products & Services,
- 11.5.8.3. SWOT Analysis,
- 11.5.8.4. Recent Developments,
- 11.5.8.5. Strategies,
- 11.5.8.6. Financials (Based on Availability)
- 11.5.9. Pfizer Inc.
- 11.5.9.1. Overview,
- 11.5.9.2. Products & Services,
- 11.5.9.3. SWOT Analysis,
- 11.5.9.4. Recent Developments,
- 11.5.9.5. Strategies,
- 11.5.9.6. Financials (Based on Availability)
- 11.5.10. Other Prominent Players
- 11.5.10.1. Overview,
- 11.5.10.2. Products & Services,
- 11.5.10.3. SWOT Analysis,
- 11.5.10.4. Recent Developments,
- 11.5.10.5. Strategies,
- 11.5.10.6. Financials (Based on Availability)
- 12. Strategic Recommendations
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook